Apellis Pharmaceuticals, Inc.
US ˙ NasdaqGS ˙ US03753U1060
DETTE SYMBOL ER IKKE LÆNGERE AKTIVT

SecurityAPLS / Apellis Pharmaceuticals, Inc.
InstitutionCitadel Advisors Llc
ManagerKen Griffin
Latest Disclosed Ownership38,887 shares
Latest Disclosed Value $ 1,564,424
Citadel Advisors Llc ownership in APLS / Apellis Pharmaceuticals, Inc.

On May 15, 2026 - Citadel Advisors Llc filed a 13F-HR form disclosing ownership of 38,887 shares of Apellis Pharmaceuticals, Inc. (US:APLS) valued at $1,564,424 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 648,229 shares of Apellis Pharmaceuticals, Inc.. This represents a change in shares of -94.00% during the quarter. The current value of the position is $1,595,534 USD.

Citadel Advisors Llc has a history of taking positions in derivatives of the underlying security (APLS) in the form of stock options. The firm currently holds call options representing 155,800 of underlying shares valued at $6,267,834 USD and put options representing 68,600 of underlying shares valued at $2,759,778 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

APLS / Apellis Pharmaceuticals, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F APELLIS PHARMACEUTICALS COM 03753U106 38,887 -609,342 -94.00 1,564 -90.39 0.0002
2026-02-17 2025-12-31 13F APELLIS PHARMACEUTICALS COM 03753U106 648,229 61,777 10.53 16,284 22.70 0.0024
2025-11-14 2025-09-30 13F APELLIS PHARMACEUTICALS COM 03753U106 586,452 143,892 32.51 13,271 73.25 0.0020
2025-08-14 2025-06-30 13F APELLIS PHARMACEUTICALS COM 03753U106 442,560 218,464 97.49 7,661 56.33 0.0013
2025-05-15 2025-03-31 13F APELLIS PHARMACEUTICALS COM 03753U106 224,096 111,673 99.33 4,901 36.60 0.0009
2025-02-14 2024-12-31 13F APELLIS PHARMACEUTICALS COM 03753U106 112,423 -85,710 -43.26 3,587 -37.22 0.0006
2024-11-14 2024-09-30 13F APELLIS PHARMACEUTICALS COM 03753U106 198,133 44,242 28.75 5,714 -3.20 0.0011
2024-08-14 2024-06-30 13F APELLIS PHARMACEUTICALS COM 03753U106 153,891 -1,032,191 -87.03 5,903 -91.53 0.0012
2024-05-15 2024-03-31 13F APELLIS PHARMACEUTICALS COM 03753U106 1,186,082 900,965 316.00 69,718 308.49 0.0134
2024-02-14 2023-12-31 13F APELLIS PHARMACEUTICALS COM 03753U106 285,117 270,370 1,833.39 17,067 2,947.68 0.0034
2023-11-14 2023-09-30 13F APELLIS PHARMACEUTICALS COM 03753U106 14,747 -513,825 -97.21 561 -98.84 0.0001
2023-08-14 2023-06-30 13F APELLIS PHARMACEUTICALS COM 03753U106 528,572 354,512 203.67 48,153 319.44 0.0100
2023-05-15 2023-03-31 13F APELLIS PHARMACEUTICALS COM 03753U106 174,060 168,791 3,203.47 11,481 4,120.59 0.0025
2023-02-14 2022-12-31 13F APELLIS PHARMACEUTICALS COM 03753U106 5,269 -42,892 -89.06 272 -91.73 0.0001
2022-11-14 2022-09-30 13F APELLIS PHARMACEUTICALS COM 03753U106 48,161 -149,298 -75.61 3,289 -63.16 0.0007
2022-08-15 2022-06-30 13F APELLIS PHARMACEUTICALS COM 03753U106 197,459 -231,793 -54.00 8,929 -59.06 0.0023
2022-05-16 2022-03-31 13F APELLIS PHARMACEUTICALS COM 03753U106 429,252 -524,479 -54.99 21,810 -51.63 0.0045
2022-02-14 2021-12-31 13F APELLIS PHARMACEUTICALS COM 03753U106 953,731 -904,701 -48.68 45,092 -26.39 0.0092
2021-11-15 2021-09-30 13F APELLIS PHARMACEUTICALS Cmn 03753U106 1,858,432 1,505,416 426.44 61,254 174.55 0.0127
2021-08-16 2021-06-30 13F APELLIS PHARMACEUTICALS COM 03753U106 353,016 300,464 571.75 22,311 889.40 0.0050
2021-05-21 2021-03-31 13F/A-1 APELLIS PHARMACEUTICALS COM 03753U106 52,552 -1,384,394 -96.34 2,255 -97.26 0.0006
2021-05-17 2021-03-31 13F APELLIS PHARMACEUTICALS COM 03753U106 52,552 -1,384,394 2,255 0.0006
2021-02-16 2020-12-31 13F APELLIS PHARMACEUTICALS COM 03753U106 1,436,946 -765,312 -34.75 82,193 23.71 0.0214
2020-11-16 2020-09-30 13F APELLIS PHARMACEUTICALS COM 03753U106 2,202,258 832,498 60.78 66,442 48.52 0.0188
2020-08-14 2020-06-30 13F APELLIS PHARMACEUTICALS Cmn 03753U106 1,369,760 634,920 86.40 44,737 127.24 0.0160
2020-05-15 2020-03-31 13F APELLIS PHARMACEUTICALS Cmn 03753U106 734,840 178,480 32.08 19,687 15.56 0.0088
2020-02-14 2019-12-31 13F APELLIS PHARMACEUTICALS Cmn 03753U106 556,360 -85,360 -13.30 17,036 4.77 0.0074
2019-08-14 2019-06-30 13F APELLIS PHARMACEUTICALS Cmn 03753U106 641,720 -303,464 -32.11 16,261 -11.77 0.0075
2019-05-15 2019-03-31 13F APELLIS PHARMACEUTICALS Cmn 03753U106 945,184 894,915 1,780.25 18,431 2,679.94 0.0092
2019-02-14 2018-12-31 13F APELLIS PHARMACEUTICALS Cmn 03753U106 50,269 -13,443 -21.10 663 -41.43 0.0004
2018-11-13 2018-09-30 13F APELLIS PHARMACEUTICALS Cmn 03753U106 63,712 52,445 465.47 1,132 358.30 0.0005
2018-08-14 2018-06-30 13F/A-1 APELLIS PHARMACEUTICALS Cmn 03753U106 11,267 11,267 247 0.0001
2018-08-10 2018-06-30 13F APELLIS PHARMACEUTICALS Cmn 03753U106 11,267 247 0.0001
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F APELLIS PHARMACEUTICALS COM Call 155,800 11.13 6,268 77.99 n/a n/a n/a
2026-02-17 2025-12-31 13F APELLIS PHARMACEUTICALS COM Call 140,200 -5.21 3,522 5.23 n/a n/a n/a
2025-11-14 2025-09-30 13F APELLIS PHARMACEUTICALS COM Call 147,900 31.12 3,347 71.41 n/a n/a n/a
2025-08-14 2025-06-30 13F APELLIS PHARMACEUTICALS COM Call 112,800 0.53 1,953 -20.42 n/a n/a n/a
2025-05-15 2025-03-31 13F APELLIS PHARMACEUTICALS COM Call 112,200 -16.46 2,454 -42.75 n/a n/a n/a
2025-02-14 2024-12-31 13F APELLIS PHARMACEUTICALS COM Call 134,300 -6.67 4,286 3.25 n/a n/a n/a
2024-11-14 2024-09-30 13F APELLIS PHARMACEUTICALS COM Call 143,900 -34.08 4,150 -50.44 n/a n/a n/a
2024-08-14 2024-06-30 13F APELLIS PHARMACEUTICALS COM Call 218,300 58.88 8,374 3.68 n/a n/a n/a
2024-05-15 2024-03-31 13F APELLIS PHARMACEUTICALS COM Call 137,400 -65.21 8,076 -65.83 n/a n/a n/a
2024-02-14 2023-12-31 13F APELLIS PHARMACEUTICALS COM Call 394,900 -41.92 23,639 -8.60 n/a n/a n/a
2023-11-14 2023-09-30 13F APELLIS PHARMACEUTICALS COM Call 679,900 420.60 25,863 117.39 n/a n/a n/a
2023-08-14 2023-06-30 13F APELLIS PHARMACEUTICALS COM Call 130,600 -40.23 11,898 -17.45 n/a n/a n/a
2023-05-15 2023-03-31 13F APELLIS PHARMACEUTICALS COM Call 218,500 -24.45 14,412 -3.62 n/a n/a n/a
2023-02-14 2022-12-31 13F APELLIS PHARMACEUTICALS COM Call 289,200 41.56 14,955 7.17 n/a n/a n/a
2022-11-14 2022-09-30 13F APELLIS PHARMACEUTICALS COM Call 204,300 12.01 13,954 69.18 n/a n/a n/a
2022-08-15 2022-06-30 13F APELLIS PHARMACEUTICALS COM Call 182,400 -11.41 8,248 -21.16 n/a n/a n/a
2022-05-16 2022-03-31 13F APELLIS PHARMACEUTICALS COM Call 205,900 -13.20 10,462 -6.71 n/a n/a n/a
2022-02-14 2021-12-31 13F APELLIS PHARMACEUTICALS COM Call 237,200 -60.06 11,215 -42.71 n/a n/a n/a
2021-11-15 2021-09-30 13F APELLIS PHARMACEUTICALS Cmn Call 593,900 507.26 19,575 216.70 n/a n/a n/a
2021-08-16 2021-06-30 13F APELLIS PHARMACEUTICALS COM Call 97,800 52.10 6,181 124.03 n/a n/a n/a
2021-05-21 2021-03-31 13F/A APELLIS PHARMACEUTICALS COM Call 64,300 41.32 2,759 5.99 n/a n/a n/a
2021-05-17 2021-03-31 13F APELLIS PHARMACEUTICALS COM Call 64,300 2,759 n/a n/a n/a
2021-02-16 2020-12-31 13F APELLIS PHARMACEUTICALS COM Call 45,500 100.44 2,603 280.00 n/a n/a n/a
2020-11-16 2020-09-30 13F APELLIS PHARMACEUTICALS COM Call 22,700 46.45 685 35.38 n/a n/a n/a
2020-08-14 2020-06-30 13F APELLIS PHARMACEUTICALS Cmn Call 15,500 30.25 506 58.62 n/a n/a n/a
2020-05-15 2020-03-31 13F APELLIS PHARMACEUTICALS Cmn Call 11,900 -38.97 319 -46.57 n/a n/a n/a
2020-02-14 2019-12-31 13F APELLIS PHARMACEUTICALS Cmn Call 19,500 597 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F APELLIS PHARMACEUTICALS COM Put 68,600 -44.68 2,760 -11.40 n/a n/a n/a
2026-02-17 2025-12-31 13F APELLIS PHARMACEUTICALS COM Put 124,000 8.96 3,115 20.93 n/a n/a n/a
2025-11-14 2025-09-30 13F APELLIS PHARMACEUTICALS COM Put 113,800 53.16 2,575 100.23 n/a n/a n/a
2025-08-14 2025-06-30 13F APELLIS PHARMACEUTICALS COM Put 74,300 -16.05 1,286 -33.54 n/a n/a n/a
2025-05-15 2025-03-31 13F APELLIS PHARMACEUTICALS COM Put 88,500 -33.91 1,935 -54.71 n/a n/a n/a
2025-02-14 2024-12-31 13F APELLIS PHARMACEUTICALS COM Put 133,900 -26.06 4,273 -18.19 n/a n/a n/a
2024-11-14 2024-09-30 13F APELLIS PHARMACEUTICALS COM Put 181,100 5.11 5,223 -20.99 n/a n/a n/a
2024-08-14 2024-06-30 13F APELLIS PHARMACEUTICALS COM Put 172,300 -41.19 6,609 -61.62 n/a n/a n/a
2024-05-15 2024-03-31 13F APELLIS PHARMACEUTICALS COM Put 293,000 -28.26 17,223 -29.55 n/a n/a n/a
2024-02-14 2023-12-31 13F APELLIS PHARMACEUTICALS COM Put 408,400 32.38 24,447 108.32 n/a n/a n/a
2023-11-14 2023-09-30 13F APELLIS PHARMACEUTICALS COM Put 308,500 43.09 11,735 -40.25 n/a n/a n/a
2023-08-14 2023-06-30 13F APELLIS PHARMACEUTICALS COM Put 215,600 15.36 19,641 59.33 n/a n/a n/a
2023-05-15 2023-03-31 13F APELLIS PHARMACEUTICALS COM Put 186,900 -4.50 12,328 21.82 n/a n/a n/a
2023-02-14 2022-12-31 13F APELLIS PHARMACEUTICALS COM Put 195,700 107.75 10,120 57.27 n/a n/a n/a
2022-11-14 2022-09-30 13F APELLIS PHARMACEUTICALS COM Put 94,200 47.42 6,434 122.63 n/a n/a n/a
2022-08-15 2022-06-30 13F APELLIS PHARMACEUTICALS COM Put 63,900 -19.11 2,890 -28.00 n/a n/a n/a
2022-05-16 2022-03-31 13F APELLIS PHARMACEUTICALS COM Put 79,000 28.46 4,014 38.03 n/a n/a n/a
2022-02-14 2021-12-31 13F APELLIS PHARMACEUTICALS COM Put 61,500 -81.02 2,908 -72.78 n/a n/a n/a
2021-11-15 2021-09-30 13F APELLIS PHARMACEUTICALS Cmn Put 324,100 264.57 10,682 90.14 n/a n/a n/a
2021-08-16 2021-06-30 13F APELLIS PHARMACEUTICALS COM Put 88,900 209.76 5,618 356.01 n/a n/a n/a
2021-05-21 2021-03-31 13F/A APELLIS PHARMACEUTICALS COM Put 28,700 143.22 1,232 82.52 n/a n/a n/a
2021-05-17 2021-03-31 13F APELLIS PHARMACEUTICALS COM Put 28,700 1,232 n/a n/a n/a
2021-02-16 2020-12-31 13F APELLIS PHARMACEUTICALS COM Put 11,800 -0.84 675 88.02 n/a n/a n/a
2020-11-16 2020-09-30 13F APELLIS PHARMACEUTICALS COM Put 11,900 -77.63 359 -79.34 n/a n/a n/a
2020-08-14 2020-06-30 13F APELLIS PHARMACEUTICALS Cmn Put 53,200 -57.13 1,738 -47.73 n/a n/a n/a
2020-05-15 2020-03-31 13F APELLIS PHARMACEUTICALS Cmn Put 124,100 107.87 3,325 81.89 n/a n/a n/a
2020-02-14 2019-12-31 13F APELLIS PHARMACEUTICALS Cmn Put 59,700 1,828 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.